Pimm M V, Gribben S J
Cancer Research Campaign Laboratories, University of Nottingham, UK.
J Cancer Res Clin Oncol. 1992;119(1):41-5. doi: 10.1007/BF01209486.
We have previously shown that Balb/c mice immunised against syngeneic monoclonal antibodies (mAbs), so that they have anti-idiotypic responses against those mAbs, will clear the mAbs from the circulation as a result of immune complex formation. We report here that with three separate mAbs, this clearance of complexes can result in toxicity to the animals. This was particularly severe with one mAb (NCRC-2), in some cases leading to death. It was not seen with Fab/c or Fab fragments of NCRC-2. This toxic response could be passively transferred with serum, indicating that it was due to formation of immune complexes or to their subsequent clearance. Treatment of mice with cobra venom factor, to reduce complement levels, reduced clearance of complexes but had no effect on toxicity. The anti-histamine pyrilamine did not reduce toxicity. This is one of only a few situations in which an anti-(mouse antibody) response has been reported to be potentially dangerous, and is particularly remarkable since it occurs as a result of such a limited anti-antibody response.
我们之前已经表明,用同基因单克隆抗体(mAb)免疫Balb/c小鼠,使其对这些mAb产生抗独特型反应,会因免疫复合物的形成而将mAb从循环中清除。我们在此报告,对于三种不同的mAb,这种复合物的清除会导致动物中毒。其中一种mAb(NCRC-2)的情况尤为严重,在某些情况下会导致死亡。NCRC-2的Fab/c或Fab片段则未出现这种情况。这种毒性反应可以通过血清被动转移,表明这是由于免疫复合物的形成或其随后的清除所致。用眼镜蛇毒因子处理小鼠以降低补体水平,可减少复合物的清除,但对毒性没有影响。抗组胺药吡苄明不能降低毒性。这是仅有的少数几种抗(小鼠抗体)反应被报道可能具有危险性的情况之一,而且特别值得注意的是,它是由于如此有限的抗抗体反应而发生的。